Achilles Therapeutics plc (ACHL) - Quarterly Income Statement

Home
ACHL
Financials

0.94 (USD) • At close September 19, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1
Revenue Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.58	0	0	0	0.18	0	0
Cost of Revenue Numbers are in millions	1.178	1.179	1.158	1.197	1.304	0	0.837	0.892	0.892	1.047	0.838	0.896	0.798	0	0	0.29	0	0	0	0.09	0.045	0.045
Gross Profit Numbers are in millions	-1.178	-1.179	-1.158	-1.197	-1.304	0	-0.837	-0.892	-0.892	-1.047	-0.838	-0.896	-0.798	0	0	0.29	0	0	0	0.09	-0.045	-0.045
Gross Profit Ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0.5	0	0
Reseach & Development Expenses Numbers are in millions	13.65	10.134	16.03	14.712	13.774	13.868	18.876	10.597	14.776	13.014	11.807	10.697	10.844	8.876	8.961	5.291	4.547	3.83	2.746	1.232	2.547	2.547
General & Administrative Expenses Numbers are in millions	4.164	4.159	3.622	4.384	4.318	4.685	3.958	5.437	5.77	5.955	6.653	5.041	5.445	4.832	3.958	3.009	2.395	1.736	1.689	1.011	1.002	1.002
Selling & Marketing Expenses Numbers are in millions	-1.174	-1.182	-1.126	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	2.99	2.977	2.496	4.384	4.318	4.685	3.958	5.437	5.77	5.955	6.653	5.041	5.445	4.832	3.958	3.009	2.395	1.736	1.689	1.011	1.002	1.002
Other Expenses Numbers are in millions	1.427	2.002	1.389	2.389	1.212	1.091	-1.181	3.599	3.271	1.629	0.226	2.806	0.146	-0.045	0.002	0.09	0.087	0.352	-16.731	-6.941	-6.941	-6.941
Operating Expenses Numbers are in millions	16.641	13.112	18.526	19.096	18.092	18.553	22.834	16.034	20.546	18.969	18.46	15.738	16.289	13.708	12.919	8.3	6.942	5.566	4.558	2.438	3.497	3.497
Operating Income Numbers are in millions	-17.819	-14.291	-19.684	-19.096	-18.092	-18.553	-22.834	-16.034	-20.546	-18.969	-18.46	-15.738	-16.289	-13.708	-12.919	-8.3	-6.942	-5.566	-4.435	-2.243	-3.549	-3.549
Operating Income Ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-14.31	0	0	0	-12.461	0	0
Total Other Income Expenses Net Numbers are in millions	1.429	2.001	1.401	2.389	1.212	1.091	-1.181	3.599	3.271	1.629	0.226	2.806	0.146	-0.045	0.002	0.09	0.087	0.352	-0.123	-0.105	0.007	0.007
Income Before Tax Numbers are in millions	-16.39	-12.29	-18.283	-16.707	-16.88	-17.462	-24.015	-12.435	-17.275	-17.34	-18.234	-12.932	-16.143	-13.753	-12.917	-8.21	-6.855	-5.214	-4.558	-2.348	-3.542	-3.542
Income Before Tax Ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-14.155	0	0	0	-13.044	0	0
Income Tax Expense Numbers are in millions	0.008	-0.023	0.509	-0.024	-0.034	0.044	0.041	0.041	0.014	0.015	-0.004	0.016	0.013	0.012	0.003	0.001	0.001	0.001	0.001	0	0	0
Net Income Numbers are in millions	-16.398	-12.267	-18.792	-16.683	-16.846	-17.506	-24.056	-12.476	-17.289	-17.355	-18.23	-12.948	-16.156	-13.765	-12.92	-8.21	-6.855	-5.214	-4.558	-2.348	-3.542	-3.542
Net Income Ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-14.155	0	0	0	-13.044	0	0
EPS Numbers are in millions	-0.41	-0.3	-0.47	-0.42	-0.42	-0.44	-0.61	-0.32	-0.44	-0.45	-0.64	-0.34	-0.45	-8.38	-0.32	-5	-4.17	-3.18	-6.3	-3.66	-5.89	-5.89
EPS Diluted Numbers are in millions	-0.41	-0.3	-0.47	-0.42	-0.42	-0.44	-0.61	-0.32	-0.44	-0.45	-0.64	-0.34	-0.45	-8.38	-0.32	-5	-4.17	-3.18	-6.29	-3.66	-5.89	-5.89
EBITDA Numbers are in millions	-16.641	-13.112	-18.526	-19.096	-18.092	-18.553	-22.834	-16.034	-19.63	-17.916	-17.623	-14.906	-15.459	-12.919	-12.52	-8.3	-6.942	-5.469	-4.336	-2.162	-3.488	-3.488
EBITDA Ratio Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-14.31	0	0	0	-12.011	0	0

Achilles Therapeutics plc

NASDAQ:ACHL Add to watchlist

NASDAQ:ACHL